Ann-Kathrin Dachtler

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Boston Children's Hospital

Edith Cowan University

Harvard Stem Cell Institute

Ann-Kathrin Dachtler is an author at Brigham and Women's Hospital specializing in regenerative medicine, good manufacturing practice compliance, and wound inflammation.

ORCID

Publications per year

2021–2021

Publications

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

Alexandra Norrick, Jasmina Esterlechner, Elke Niebergall‐Roth et al. · Stem Cell Research & Therapy · 2021 · 37 citations · Full text

Pharmacy, Pharmaceutical Biotechnology, Translational Sciences +17

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

Andreas Kerstan, Kathrin Dieter, Elke Niebergall‐Roth et al. · JID Innovations · 2021 · 37 citations · Full text

Veterinary Medicine, Clinical Sciences, Immunology +15

1–2 of 2